Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

A Kingston, Ont., resident says he's finally getting the treatment he needs for a rare cancer he was diagnosed with since the ...

To reduce this risk, individuals should avoid smoking and take steps to stay warm and healthy during cold weather, such as ...

Rowan's parents are campaigning to make genetic testing part of routine screening during pregnancy after their baby boy died ...

At the time of writing this, I am 22 years old and I haven’t had penetrative sex in two years. It seems that the recurrent ...

Cows may serve as a potential host for influenza A virus, with implications for zoonotic transmission to humans.

LTI-03 reduced tissue scarring-promoting protein levels in the first group of IPF patients participating in a Phase 1b trial, ...

Naturally I felt very relieved to have a diagnosis, but I was annoyed to have yet another medical condition to deal with. I ...

Cediranib maleate is under clinical development by AstraZeneca and currently in Phase II for Small-Cell Lung Cancer.

Alveolar capillary dysplasia (ACD) is a rare, life-threatening lung disease that affects newborns. It is characterized by the abnormal development of the capillaries in the lungs, which prevents ...